Delivery Order SPE2DH25D0001-SPE2D426F3832
- Not listed
- Abbott Laboratories Inc., through its Abbott Point of Care division, was awarded a delivery order valued at $1,230.50 on November 3, 2025, for the METLYTE 8 Panel with an ultimate completion date of November 5, 2025. This fixed-price delivery order with economic price adjustment was issued by the Defense Logistics Agency Medical Supply Chain, a defense-focused federal agency responsible for medical supply procurement. The contract was awarded without a set-aside designation under full and open...
- Abbott Laboratories Inc., through its Abbott Point of Care division, was awarded a fixed-price delivery order valued at $1,230.50 on October 30, 2025, for the METLYTE 8 PANEL, with an ultimate completion date of November 3, 2025. The contract was issued by the Defense Logistics Agency's Medical Supply Chain division without a set-aside designation and will be performed in North Chicago, Illinois, where Abbott maintains its headquarters. The pricing structure includes economic price adjustment...
- Abbott Laboratories Inc., through its Abbott Point of Care division, was awarded a delivery order valued at $3,691.50 by the Medical Supply Chain, a Defense agency function, on October 8, 2025. The contract, identified as METLYTE 8 PANEL, represents a fixed-price delivery order with economic price adjustment provisions and is scheduled for completion by October 10, 2025. The work will be performed in North Chicago, Illinois, where Abbott maintains its headquarters and point-of-care division....
- Abbott Laboratories Inc., through its Abbott Point of Care division, was awarded a delivery order valued at $3,691.50 for the supply of METLYTE 8 PANEL products on September 2, 2025, with an ultimate completion date of September 4, 2025. The contract utilizes fixed price pricing with economic price adjustment and will be performed in North Chicago, Illinois. This delivery order was issued without a set-aside designation, indicating full and open competition. The award is funded by the Defense...
- Abbott Laboratories Inc., through its Abbott Point of Care division, was awarded a delivery order for METLYTE 8 PANEL products valued at $2,461.00 on August 11, 2025, with an ultimate completion date of August 13, 2025. The contract utilizes fixed price pricing with economic price adjustment terms and will be performed in North Chicago, Illinois. This delivery order was awarded without a set-aside designation, indicating full and open competition. The funding source is the Defense Medical Supply...
- Abbott Laboratories Inc., through its Abbott Point of Care division, was awarded a delivery order for METLYTE 8 PANEL products valued at $3,570.75 on June 26, 2025, with an ultimate completion date of June 30, 2025. This fixed-price contract with economic price adjustment was awarded without a set-aside designation, indicating full and open competition. The contract is being performed in North Chicago, Illinois, and is funded by the Defense Medical Supply Chain, a defense-oriented federal...
- Abbott Laboratories Inc., through its Abbott Point of Care division, was awarded a delivery order valued at $3,691.50 for the supply of METLYTE 8 Panel products under a fixed-price contract with economic price adjustment provisions. The award, issued on September 11, 2025, with an ultimate completion date of September 15, 2025, represents a non-competitive procurement without set-aside designation. The work will be performed at Abbott's facility in North Chicago, Illinois, and is funded...
- Abbott Laboratories Inc., through its Abbott Point of Care division, was awarded a delivery order valued at $1,845.75 for the METLYTE 8 Panel on August 6, 2025, with an ultimate completion date of August 8, 2025. This fixed-price delivery order with economic price adjustment was issued without a set-aside designation, indicating full and open competition. The contract is being performed in North Chicago, Illinois, and is funded by the Defense Medical Supply Chain, a defense-focused federal...
- Abbott Laboratories Inc. has been awarded a delivery order valued at $1,904.40 for METLYTE 8 PANEL under a fixed-price contract with economic price adjustment provisions. This contract, with an ultimate completion date of August 7, 2025, was awarded on August 5, 2025, by the Defense Department's Medical Supply Chain organization. The work will be performed in North Chicago, Illinois, where Abbott maintains its global headquarters. This delivery order was awarded through full and open competition...
- Abbott Laboratories Inc., through its Abbott Point of Care division, was awarded a $1,446.00 fixed-price delivery order (Contract No. 4570124723) by the Defense Logistics Agency Medical Supply Chain on November 29, 2025, with completion expected by December 2, 2025. The delivery order, titled "Panel Piccolo Comprehensive Metabolic Analysis," will be performed at Abbott's facility in North Chicago, Illinois. This award represents a task order under Abbott's existing indefinite...
- SPE2DH25D0001Indefinite Delivery Contract
- SPE2DH25D0001-SPE2D426F3832Delivery Order
Abbott Laboratories Inc., through its Abbott Point of Care division, was awarded a $3,691.50 fixed-price delivery order (Contract 4570323044) on December 18, 2025, for METLYTE 8 Panel products, with an ultimate completion date of December 22, 2025. The award was issued by the Defense Logistics Agency Medical Supply Chain, a defense-focused federal agency responsible for procuring medical supplies and equipment for Department of Defense operations. The contract utilizes fixed-price pricing with economic price adjustment provisions and was awarded on a competitive basis without any small business set-aside designation. Performance will be completed at Abbott's North Chicago, Illinois facility. This delivery order represents a continuation of Abbott's established role as a key federal medical supply contractor, leveraging the company's extensive blanket purchase agreements and indefinite delivery vehicles across multiple Veterans Integrated Service Networks and Defense Health Agency contracts. Abbott's METLYTE product line, part of its point-of-care diagnostics portfolio, provides critical electrolyte testing capabilities for clinical laboratory and field-deployable applications. The company's federal contracting approach emphasizes efficient procurement through cost-effective delivery mechanisms, supporting the Defense Logistics Agency's mission to supply medical products and diagnostic equipment to military and defense healthcare operations. The brief performance timeline reflects the consumable nature of the ordered diagnostic supplies.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.7k | 12/17/25 |